Home/Immunic/Dr. Duane Nash

DD

Dr. Duane Nash

Chairman of the Supervisory Board

Therapeutic Areas

Multiple Sclerosis Inflammatory Bowel Disease Autoimmune Diseases

Immunic Pipeline

Drug	Indication	Phase
Vidofludimus calcium (IMU-838)	Relapsing-Remitting Multiple Sclerosis (RRMS)	Phase 3
IMU-856	Celiac Disease / GI Barrier Function	Phase 1b
IMU-935 / IMU-856	Psoriasis / Inflammatory Diseases	Preclinical / Phase 1

Leadership Team at Immunic

Dr. Daniel Vitt

President, CEO, and Chairman of the Management Board

Dr. Andreas Muehler

Chief Medical Officer

Dr. H. Daniel Perez

View full Immunic profile